Synopsis
Confirm a persistent raised-TSH normal-free-T4 pattern, estimate likelihood of progression and benefit, and use treatment trials or surveillance without medicalising transient results.
- Subclinical hypothyroidism is a persistently raised TSH with free T4 inside the assay reference range after transient and analytical causes are excluded.
- Confirm the abnormality on two samples separated by about three months before treatment in a stable non-pregnant adult, unless a different urgent context applies.
- NICE advises considering levothyroxine when TSH is 10 mIU/L or higher on two measurements three months apart.
- For symptomatic adults under 65 with TSH above range but below 10, NICE supports considering a six-month therapeutic trial after repeat confirmation.
- Age, symptoms, previous radioiodine or surgery, goitre and thyroid peroxidase antibody positivity modify the chance that a raised TSH reflects persistent thyroid disease.
- If symptoms do not improve once TSH is within range during a treatment trial, consider stopping levothyroxine and look for alternative causes rather than escalating indefinitely.
- Untreated patients with features suggesting underlying thyroid disease usually need annual TSH and free T4; those without such features may be checked every two to three years.
- Pregnancy, planned conception and fertility treatment use separate obstetric-endocrine thresholds and should not be managed from the ordinary adult algorithm.
- In older adults, mild TSH elevation is more often transient and treatment can cause harm through over-replacement, atrial fibrillation and bone loss.
Key red flags
A free T4 below range means overt hypothyroidism, not subclinical disease. Marked clinical deterioration, hypothermia, bradycardia or reduced consciousness requires urgent evaluation regardless of an earlier mild profile.
Known pregnancy, trying to conceive or assisted reproduction changes the risk-benefit calculation and reference ranges; arrange prompt obstetric or endocrine advice instead of waiting three months routinely.
Investigation priorities
Confirm persistence and exclude evolution to overt deficiency.
Management branches
A stable adult has raised TSH with free T4 within range.
- Review acute illness, pregnancy possibility, medicines, supplements, prior thyroid treatment and the magnitude and chronology of TSH elevation.
- Repeat TSH and free T4 after approximately three months in the routine pathway, adding TPO antibodies once when autoimmune disease status is informative.
- Reclassify promptly if free T4 becomes low, and refer when results suggest pituitary disease, assay interference or another complex explanation.
Treatment is not indicated, not beneficial or not preferred.
- Check TSH and free T4 annually when TPO antibodies, previous thyroid intervention or another feature indicates underlying thyroid disease.
- Use a two-to-three-year interval when there are no underlying-disease features, with earlier testing if symptoms evolve or medicines change.
- Provide an explicit pregnancy-planning instruction and advise urgent review for marked deterioration rather than waiting for the scheduled blood test.